(Q36234349)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16109361%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Neurological complications of HIV infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16109361%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16109361%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Justin C McArthur

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16109361%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Avi Nath

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16109361%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16109361%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16109361%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16109361%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16109361%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

543-555

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16109361%20AND%20SRC:MED&resulttype=core&format=json

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Chemokine receptors: gateways to inflammation and infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

DC-SIGN: a guide to some mysteries of dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Use of HIV viral load in clinical practice: back to the future

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Targeting neurotherapeutic agents through the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

HIV infection and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Epidemiology of human immunodeficiency virus encephalopathy in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987–93) and differential incidence according to mode of transmission of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

The impact of zidovudine on dementia-free survival in a population of HIV-positive men and women on antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Circulating proviral HIV DNA and HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Dysregulation of sphingolipid and sterol metabolism by ApoE4 in HIV dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Human immunodeficiency virus (HIV) infection and the nervous system: report from the American Academy of Neurology AIDS Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

HIV dementia: an evolving disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Pediatric acquired immunodeficiency syndrome. Neurologic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Progressive encephalopathy in children with acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

HIV-1 infection of subcortical astrocytes in the pediatric central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

A Neuronal and Neuroanatomical Correlate of HIV-1 Encephalopathy Relative to HIV-1 Encephalitis in HIV-1-infected Children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Changing patterns in the neuropathogenesis of HIV during the HAART era.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Multifocal vacuolar leucoencephalopathy: a distinct HIV-associated lesion of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Cerebrospinal fluid beta 2 microglobulin in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

CSF soluble Fas correlates with the severity of HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Assessment of neuronal density in the putamen in human immunodeficiency virus (HIV) infection. Application of stereology and spatial analysis of quadrats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Astrocyte specific viral strains in HIV dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Characterization of a novel binding site for the human immunodeficiency virus type 1 envelope protein gp120 on human fetal astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Virological and molecular parameters of HIV-1 infection of human embryonic astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Loss of neurons in the frontal cortex in AIDS brains

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Spectrum of human immunodeficiency virus-associated neocortical damage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Selective neuronal vulnerability in HIV encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

AIDS dementia complex: evaluation with proton MR spectroscopic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

SIV infection of macaques--modeling the progression to AIDS dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Cytokines in the brain during viral infection: clues to HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Rate and severity of HIV-associated dementia (HAD): correlations with Gp41 and iNOS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Matrix metalloproteinases and diseases of the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Cytotoxicity by matrix metalloprotease-1 in organotypic spinal cord and dissociated neuronal cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Synaptic laminin prevents glial entry into the synaptic cleft

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Neurobiological aspects of human immunodeficiency virus infection:Neurotoxic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Distinct biological and serological properties of human immunodeficiency viruses from the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Biological characterization of paired human immunodeficiency virus type 1 isolates from blood and cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Human immunodeficiency virus-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Antiretroviral therapy in HIV infection: are neurologically active drugs important?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Neuroprotective and anti-human immunodeficiency virus activity of minocycline

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Clinical trials in HIV-associated cognitive impairment: Cognitive and functional outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: an autopsy-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

The role of somatosensory evoked potentials in the diagnosis of AIDS-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

HIV antigen and DNA in AIDS spinal cords correlate with macrophage infiltration but not with vacuolar myelopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Abnormal cobalamin-dependent transmethylation in AIDS-associated myelopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Vacuolar myelopathy in transgenic mice expressing human immunodeficiency virus type 1 proteins under the regulation of the myelin basic protein gene promoter

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

A pilot study of L-methionine for the treatment of AIDS-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

The Guillain-Barré syndrome and human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Neurologic manifestations of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Peripheral nervous system involvement in a large cohort of human immunodeficiency virus-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Distal sensory polyneuropathy in a cohort of HIV-infected children over five years of age

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Markers of immune activation and viral load in HIV-associated sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Another tool for the neurologist's toolbox

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Gracile tract degeneration in patients with sensory neuropathy and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

HIV neuropathy: insights in the pathology of HIV peripheral nerve disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Increased NADPH-diaphorase reactivity and cytokine expression in dorsal root ganglia in acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Role of HIV in the pathogenesis of distal symmetrical peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

HIV-1 heterogeneity and cytokines. Neuropathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Human immunodeficiency virus infection of dorsal root ganglion neurons detected by polymerase chain reaction in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Expression of HIV-1 and interleukin-6 in lumbosacral dorsal root ganglia of patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

The molecular pathophysiology of pain: abnormal expression of sodium channel genes and its contributions to hyperexcitability of primary sensory neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Low-dose zalcitabine-related toxic neuropathy: frequency, natural history, and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Quantification of mitochondrial DNA in peripheral blood mononuclear cells and subcutaneous fat using real-time polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

FK506 is neuroprotective in a model of antiretroviral toxic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Erythropoietin is neuroprotective in models of HIV sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

HIV-associated sensory neuropathies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Mitochondrial DNA Levels in Fat and Blood Cells from Patients with Lipodystrophy or Peripheral Neuropathy and the Effect of 90 Days of High-Dose Coenzyme Q Treatment: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021

A novel endogenous erythropoietin mediated pathway prevents axonal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970165-4

7 January 2021